Retrospective Study of Patients With Type 2 Diabetes Mellitus on

See also
Status	Clinical Trial	Phase
Completed	`NCT01952535` - A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers	Phase 1
Completed	`NCT01196728` - Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes	Phase 1
Terminated	`NCT00997152` - Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients	Phase 2
Completed	`NCT02592421` - SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2	Phase 3
Completed	`NCT05544214` - Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects	Phase 1
Completed	`NCT01969084` - The Effect of Linagliptin on Mitochondrial and Endothelial Function	Phase 4
Terminated	`NCT01644201` - A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics	Phase 3
Completed	`NCT00995787` - Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea	Phase 1
Completed	`NCT01020123` - Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients	Phase 2
Completed	`NCT01505426` - A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients	Phase 3
Completed	`NCT01262586` - Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.	Phase 3
Completed	`NCT00561171` - Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria	Phase 2
Active, not recruiting	`NCT03912363` - Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids	N/A
Completed	`NCT01868646` - Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus	Phase 4
Active, not recruiting	`NCT06386328` - A Clinical Trial to Evaluate the Food Effect of CKD-378	Phase 1
Terminated	`NCT02749435` - A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus	N/A
Completed	`NCT00894868` - Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure	Phase 4
Recruiting	`NCT01165190` - Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans	N/A
Completed	`NCT01255085` - Yellow Pea Protein and Fibre and Short Term Food Intake	N/A
Completed	`NCT02156349` - A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.	N/A

NCT number	NCT03084965
Study type	Observational
Source	AstraZeneca
Contact
Status	Completed
Phase
Start date	May 12, 2017
Completion date	March 2, 2018

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms